Join
Live feed
·
INSIDERFilingvia Quantisnow
Phio Pharmaceuticals Corp. logo

Director Lockshin Curtis was granted 2,000 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
PHIO· Phio Pharmaceuticals Corp.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PHIO (Phio Pharmaceuticals Corp.) and more on Quantisnow.